George Tetz MD, PhD

Dr. George Tetz serves as CEO. He comes from a rich background, including industrial, academic, and nonprofit organizations. Throughout his career, George Tetz has focused on applying leading-edge genomic approaches to a variety of medical problems. G. Tetz has been in the background of numerous groundbreaking studies in the fields of medicine and microbiology. Dr. G. Tetz aimed at discovering novel regulation pathways linking gut-microbiome and neurodegenerative diseases. Author of over 15 patents in the field of microbiology and drug development. Prior to joining TGV-Therapeutics, George Tetz has worked in numerous collaborative drug discovery programs and contributed to more than 18 novel candidates moving into clinical development. In total, Dr. George Tetz has over 18 years of experience in microbiological research and drug discovery. He is currently a member of the American Chemical Society and the American Society for Microbiology.